Bryant Furlow

Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared The Lancet, New Scientist, and Oncology Nurse Advisor.

Most Recent Articles by Bryant Furlow

Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients

Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients

By

In this question-and-answer session, Cancer Therapy Advisor asked Dr Wildes about the management of multiple myeloma among older patients.

Cabozantinib for Pediatric Renal Cell Carcinoma: Two Case Studies

Cabozantinib for Pediatric Renal Cell Carcinoma: Two Case Studies

By

Two children with recurrent metastatic, TFE3 fusion-positive RCC that expressed MET experienced "prolonged disease control" following treatment with cabozantinib.

FDA Grants Atezolizumab Accelerated Approval for Bladder Cancer

FDA Grants Atezolizumab Accelerated Approval for Bladder Cancer

By

The FDA granted atezolizumab accelerated approval for first-line treatment of advanced or metastatic urothelial carcinoma regardless of PD-L1 expression status.

Prostate Cancer Risk and Fruit Intake

Prostate Cancer Risk and Fruit Intake

By

Total dietary consumption of fresh fruit — and citrus fruit consumption in particular — is associated with a modestly lower risk of developing prostate cancer.

Glioblastoma: pp65 Vaccine With High-dose Temozolomide May Improve Survival

Glioblastoma: pp65 Vaccine With High-dose Temozolomide May Improve Survival

By

With vaccine treatment, 4 patients had not progressed for more than 4.9 years and 3 patients had not progressed more than 7 years post-diagnosis.

More Articles by Bryant Furlow

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters